Depomed CEO and leadership

Ajay Patel is a Senior Vice President, Chief Accounting Officer at Depomed, Inc. and is based in Chicago, Illinois. He has worked as Director of Technical Accounting & Accounting Policy at US FOODS HOLDING CORP.; Senior Manager at EY; and VP, Controller at Depomed, Inc.. Ajay attended University of Illinois Urbana Champaign between 2002 and 2006 and University of Virginia between 2006 and 2008.

Audra Billmeyer is a Chief Of Staff at Depomed, Inc. and is based in Lake Forest, Illinois. She has worked as Human Capital Analyst at Deloitte, National Lead Campus Recruiter at Deloitte, and Leadership Development Intern at Asurion. Audra attended Vanderbilt University between 2005 and 2006 and Vanderbilt University between 2001 and 2005.

Law firm and in-house general corporate attorney with significant experience in life sciences and related high growth industries. Serves as counsel for legal and regulatory initiatives, lead role in Executive and Board review for management of legal matters. Assist to prevent or minimize legal risk to the company, and help drive legal strategy to align and achieve strategic business goals. Business partner and manager in support of key customer group(s) with oversight and guidance.

Specialties: Corporate governance and SEC compliance for pre-IPO and public companies; privacy and healthcare laws and regulation during pre and post commercialization; FDA drug and device development and approval; commercial advertising and promotion regulations, False Claims Act, Anti-Kickback Statute, OIG guidance, and industry Codes of Conduct (PhRMA Code, AdvaMed Code, etc.); managed care contracting; government pricing and reporting considerations; acquisitions and related legal business development activities.

Mark D. Booth has served as our Chief Commercial Officer since August 2009. Mr. Booth brings over 25 years of commercial and business development experience to Orexigen. Most recently, Mr. Booth served as President of Takeda Pharmaceuticals North America (TPNA) from October 2001 to June 2008, where he presided over the commercial, medical and scientific affairs, business development and all support functions. Prior to his role at TPNA, Mr. Booth served as Senior Vice President, General Manager at Immunex Corporation from January 2000 to September 2001, where he was responsible for the sales, marketing and project management functions. Before joining Immunex Corporation, Mr. Booth was at Abbott Laboratories from 1983 to 2000, where he served in a range of leadership positions including Division Vice President, General Manager for the anti-infective franchise. Mr. Booth holds a BS in Biology from Northern Illinois University and an M.B.A from Northwestern University Kellogg School of Management.

Successful C-suite Executive with expertise developing and leading medical and scientific teams within global Fortune 50 and microcap pharmaceutical, biotech, and medical device companies.

Pragmatic and innovative approach utilized to ensure value creation through organic and M&A growth. In depth experienced with change management Extensive working experience with Boards of Directors, investment partners, and analysts, in both publicly traded and privately held environments. Managed budgets exceeding $250 million

Mr. Smith is an accomplished executive and board member with extensive experience launching products and turning around businesses. Mr. Smith has an industry reputation for leadership, innovation, growing revenue and value at fortune 100, Private Equity and Venture backed companies across orphan, specialty, primary care and hospital markets. Mr. Smith's passions are building strategies that grow companies, launching products, and breaking down access barriers to the therapies that best serve patients' individual needs.